H. Kawabe

发表

Bitterness suppression of BCAA solutions by L-ornithine.

T. Uchida, Junji Mukai, Emi Tokuyama, 2006, Chemical & pharmaceutical bulletin.

Donepezil (Aricept)

H. Kawabe, Yasushi Hara, 2019, Drug Discovery in Japan.

Purification, enzymatic properties, and active site environment of a novel manganese(III)-containing acid phosphatase.

Y. Sugiura, A. Ohara, S. Fujimoto, 1981, The Journal of biological chemistry.

Bitterness suppression of BCAA solutions by L-ornithine.

T. Uchida, Junji Mukai, Emi Tokuyama, 2006, Chemical & pharmaceutical bulletin.

Leuprorelin (Leuplin, Lupron, Viadur)

H. Kawabe, Naoki Takada, 2019, Drug Discovery in Japan.

Mn(III)-containing acid phosphatase. Properties of Fe(III)-substituted enzyme and function of Mn(III) and Fe(III) in plant and mammalian acid phosphatases.

Y. Sugiura, H. Kawabe, H. Tanaka, 1984, Biochimica et biophysica acta.

Spectroscopic studies on bleomycin-iron complexes with carbon monoxide, nitric oxide, isocyanide, azide, and cyanide and comparison with iron-porphyrin complexes.

Y. Sugiura, T. Suzuki, H. Kawabe, 1982, Biochimica et biophysica acta.

First evidence for manganese binding to sulfur donor group in metalloprotein, manganese(III)-containing acid phosphatase

Y. Sugiura, Hisashi Tanaka, A. Ohara, 1981 .

New manganese(III)-containing acid phosphatase. Evidence for an intense charge-transfer band and tyrosine phenolate coordination

Y. Sugiura, Hisashi Tanaka, H. Kawabe, 1980 .

Environment of Mn(III) and its function in a red-violet colored acid phosphatase

Y. Sugiura, Hisashi Tanaka, H. Kawabe, 1983 .

31P and 17O NMR of Mn (III)-containing acid phosphatase: evidence for direct metal-phosphate interaction and oxygen exchange from water into inorganic phosphate.

Y. Sugiura, H. Kawabe, H. Tanaka, 1981, Biochemical and biophysical research communications.